Calling consciousness an "entropic engine" points to something psychologically obvious: selfhood costs energy. Maintaining a stable "me" model across time, contexts, and internal contradictions ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Forbes contributors publish independent expert analyses and insights. Nathan Goldman is a tax prof. at NC State Univ. If Trump’s tariffs in the year 2025 have taught us anything, it is that tax policy ...

Manlin Zhang’s work invites us into a liminal space, where art and science might coexist; where cognitive inquiry and the evocative language of visual expression are addressed with rigorous care. Her ...

So, you want to get good at LeetCode, especially using Java? It’s a common goal for a lot of us trying to land those tech jobs. This guide is all about helping you get there. We’ll go over how to ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

The original version of this story appeared in Quanta Magazine. In 1950 the Italian physicist Enrico Fermi was discussing the possibility of intelligent alien life with his colleagues. If alien ...

It has demonstrated the powerful ability of a quantum computer to perform certain computational tasks more efficiently than a classical computer. Thus, to show quantum advantages is a key problem in ...